300453 三鑫医疗
已收盘 11-13 15:00:00
资讯
新帖
简况
三鑫医疗(300453)披露2024年限制性股票激励计划部分限制性股票回购注销完成公告,11月12日股价下跌0.11%
证券之星 · 11-12 22:30
三鑫医疗(300453)披露2024年限制性股票激励计划部分限制性股票回购注销完成公告,11月12日股价下跌0.11%
三鑫医疗(300453)11月10日主力资金净卖出649.55万元
证券之星 · 11-10
三鑫医疗(300453)11月10日主力资金净卖出649.55万元
股市必读:三鑫医疗新发布《关于全资子公司完成工商变更(备案)登记的公告》
证券之星 · 11-09
股市必读:三鑫医疗新发布《关于全资子公司完成工商变更(备案)登记的公告》
三鑫医疗(300453)披露全资子公司完成工商变更(备案)登记公告,11月06日股价下跌1.33%
证券之星 · 11-06
三鑫医疗(300453)披露全资子公司完成工商变更(备案)登记公告,11月06日股价下跌1.33%
三鑫医疗(300453)披露向江西呈图康增加投资暨完成工商变更登记的公告,11月05日股价上涨1.88%
证券之星 · 11-05
三鑫医疗(300453)披露向江西呈图康增加投资暨完成工商变更登记的公告,11月05日股价上涨1.88%
三鑫医疗新注册《智慧仓储数据处理系统V1.0》项目的软件著作权
证券之星 · 11-04
三鑫医疗新注册《智慧仓储数据处理系统V1.0》项目的软件著作权
股市必读:三鑫医疗新发布《关于江西三鑫医疗科技股份有限公司2026年第二次临时股东会的法律意见书》
证券之星 · 11-04
股市必读:三鑫医疗新发布《关于江西三鑫医疗科技股份有限公司2026年第二次临时股东会的法律意见书》
三鑫医疗:成立了专门的数字化业务职能部门
证券之星 · 10-28
三鑫医疗:成立了专门的数字化业务职能部门
三鑫医疗:2026年前三季度公允价值变动收益为278.36万元
证券之星 · 10-28
三鑫医疗:2026年前三季度公允价值变动收益为278.36万元
股市必读:三鑫医疗新发布《关于取得金融机构股票回购专项贷款承诺函的公告》
证券之星 · 10-26
股市必读:三鑫医疗新发布《关于取得金融机构股票回购专项贷款承诺函的公告》
三鑫医疗(300453)披露取得股票回购专项贷款承诺函公告,10月22日股价下跌1.84%
证券之星 · 10-22
三鑫医疗(300453)披露取得股票回购专项贷款承诺函公告,10月22日股价下跌1.84%
股市必读:三鑫医疗新发布《关于控股二级子公司获得漏血监测器医疗器械注册证的公告》
证券之星 · 10-22
股市必读:三鑫医疗新发布《关于控股二级子公司获得漏血监测器医疗器械注册证的公告》
三鑫医疗(300453)披露股份回购方案公告,10月15日股价下跌1.54%
证券之星 · 10-15
三鑫医疗(300453)披露股份回购方案公告,10月15日股价下跌1.54%
三鑫医疗(300453.SZ)拟3000万元至6000万元回购股份
智通财经 · 10-15
三鑫医疗(300453.SZ)拟3000万元至6000万元回购股份
三鑫医疗(300453.SZ)发布前三季度业绩,归母净利润2.1亿元,同比增长13.68%
智通财经 · 10-15
三鑫医疗(300453.SZ)发布前三季度业绩,归母净利润2.1亿元,同比增长13.68%
三鑫医疗:第三季度净利润7816.83万元 同比增长11.89%
格隆汇 · 10-15
三鑫医疗:第三季度净利润7816.83万元 同比增长11.89%
股市必读:三鑫医疗新发布《关于全资子公司变更医疗器械生产许可证的公告》
证券之星 · 10-09
股市必读:三鑫医疗新发布《关于全资子公司变更医疗器械生产许可证的公告》
三鑫医疗(300453)披露相关债券2026年跟踪评级报告,9月28日股价上涨0.22%
证券之星 · 09-28
三鑫医疗(300453)披露相关债券2026年跟踪评级报告,9月28日股价上涨0.22%
“药二代”密集走向台前,大多拥有海外名校背景,将如何接好“转型”这一棒?
红星资本局 · 09-22
“药二代”密集走向台前,大多拥有海外名校背景,将如何接好“转型”这一棒?
股市必读:三鑫医疗新发布《关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》
证券之星 · 09-14
股市必读:三鑫医疗新发布《关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》
公司概况
公司名称:
江西三鑫医疗科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2015-05-15
主营业务:
江西三鑫医疗科技股份有限公司的主营业务是医疗器械研发、制造、销售和服务。公司的主要产品是血液透析制水系统、一次性使用血液透析器、血液透析浓缩液、血液透析粉、一次性使用血液透析管路、一次性使用透析用留置针、透析液过滤器、一次性使用机用采血器、血液透析设备、血液透析滤过器、血液净化补液管路、连续性血液净化管路及附件。2025年,公司成功获批组建省级工业设计中心,荣获江西省先进级智能工厂、江西省数智工厂等荣誉,并入选省级培育工业互联网平台。数字化水平全面提升,智能化运营体系成效显著。
发行价格:
12.87
{"stockData":{"symbol":"300453","market":"SZ","secType":"STK","nameCN":"三鑫医疗","latestPrice":9.44,"timestamp":1794553434000,"preClose":9.46,"halted":0,"volume":5323412,"delay":0,"changeRate":-0.0021,"floatShares":366000000,"shares":522000000,"eps":0.5562,"marketStatus":"已收盘","change":-0.02,"latestTime":"11-13 15:00:00","open":9.46,"high":9.5,"low":9.28,"amount":50002300,"amplitude":0.0233,"askPrice":9.45,"askSize":203,"bidPrice":9.44,"bidSize":171,"shortable":0,"etf":0,"ttmEps":0.5562,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794792600000},"marketStatusCode":5,"adr":0,"adjPreClose":9.46,"symbolType":"stock","openAndCloseTimeList":[[1794533400000,1794540600000],[1794546000000,1794553200000]],"highLimit":10.41,"lowLimit":8.51,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":521913275,"isCdr":false,"pbRate":3.19,"roa":"--","peRate":16.972312,"roe":"13.46%","epsLYR":0.5117,"committee":-0.077465,"marketValue":4927000000,"turnoverRate":0.0146,"status":1,"floatMarketCap":3451000000},"requestUrl":"/m/hq/s/300453/wiki","defaultTab":"wiki","newsList":[{"id":"2682974735","title":"三鑫医疗(300453)披露2024年限制性股票激励计划部分限制性股票回购注销完成公告,11月12日股价下跌0.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682974735","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682974735?lang=zh_cn&edition=full","pubTime":"2026-11-12 22:30","pubTimestamp":1794493837,"startTime":"0","endTime":"0","summary":"截至2026年11月12日收盘,三鑫医疗报收于9.46元,较前一交易日下跌0.11%,最新总市值为49.39亿元。近日,江西三鑫医疗科技股份有限公司发布《关于2024年限制性股票激励计划部分限制性股票回购注销完成暨不调整可转债转股价格的公告》。公告显示,本次回购注销171,000股限制性股票,占总股本的0.03%,涉及29人,回购价格为2.8元/股加上银行同期存款利息,回购资金总额为493,842.3元,资金来源为公司自有资金。本次回购注销完成后,公司总股本由522,084,275股减少至521,913,275股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200042411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682150361","title":"三鑫医疗(300453)11月10日主力资金净卖出649.55万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682150361","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682150361?lang=zh_cn&edition=full","pubTime":"2026-11-10 15:35","pubTimestamp":1794296142,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月10日收盘,三鑫医疗报收于9.53元,下跌0.63%,换手率1.31%,成交量4.77万手,成交额4533.44万元。11月10日的资金流向数据方面,主力资金净流出649.55万元,占总成交额14.33%,游资资金净流入362.76万元,占总成交额8.0%,散户资金净流入286.78万元,占总成交额6.33%。三鑫医疗主营业务:医疗器械研发、制造、销售和服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000026749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682293708","title":"股市必读:三鑫医疗新发布《关于全资子公司完成工商变更(备案)登记的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2682293708","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682293708?lang=zh_cn&edition=full","pubTime":"2026-11-09 04:54","pubTimestamp":1794171253,"startTime":"0","endTime":"0","summary":"截至2026年11月6日收盘,三鑫医疗报收于9.61元,下跌1.33%,换手率1.76%,成交量6.42万手,成交额6181.62万元。当日关注点交易信息汇总:11月6日主力资金净流入72.25万元,占总成交额1.17%。公司公告汇总:全资子公司河南鑫宥康医疗科技有限公司完成工商变更登记,住所及经理均已更新,新营业执照发证日期为2026年11月3日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900001414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681987938","title":"三鑫医疗(300453)披露全资子公司完成工商变更(备案)登记公告,11月06日股价下跌1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2681987938","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681987938?lang=zh_cn&edition=full","pubTime":"2026-11-06 23:37","pubTimestamp":1793979459,"startTime":"0","endTime":"0","summary":"截至2026年11月6日收盘,三鑫医疗报收于9.61元,较前一交易日下跌1.33%,最新总市值为50.17亿元。近日,三鑫医疗披露《关于全资子公司完成工商变更(备案)登记的公告》。公告显示,公司全资子公司河南鑫宥康医疗科技有限公司因经营需要,完成工商变更(备案)登记,变更内容包括住所及主要人员。公司已取得新营业执照,登记机关为郑州航空港经济综合实验区市场监督管理局,发证日期为2026年11月3日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600039154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681604076","title":"三鑫医疗(300453)披露向江西呈图康增加投资暨完成工商变更登记的公告,11月05日股价上涨1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2681604076","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681604076?lang=zh_cn&edition=full","pubTime":"2026-11-05 18:02","pubTimestamp":1793872976,"startTime":"0","endTime":"0","summary":"三鑫医疗于2026年11月5日披露《关于向江西呈图康增加投资暨完成工商变更登记的公告》。公告显示,公司于2026年9月28日召开董事会,同意使用募集资金2,400万元向全资二级子公司江西呈图康增加投资,用于实施电子加速器辐照灭菌生产线改扩建项目。本次增资后,江西呈图康注册资本由500万元增至1,651.7531万元,公司仍控制其100%股权,合并报表范围不变。近日,江西呈图康已完成工商变更登记,并取得新营业执照。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500032085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680433708","title":"三鑫医疗新注册《智慧仓储数据处理系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2680433708","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680433708?lang=zh_cn&edition=full","pubTime":"2026-11-04 05:40","pubTimestamp":1793742032,"startTime":"0","endTime":"0","summary":"证券之星消息,近日三鑫医疗(300453)新注册了《智慧仓储数据处理系统V1.0》项目的软件著作权。今年以来三鑫医疗新注册软件著作权4个,较去年同期增加了100%。结合公司2026年中报财务数据,今年上半年公司在研发方面投入了3951.63万元,同比增19.1%。通过天眼查大数据分析,江西三鑫医疗科技股份有限公司共对外投资了15家企业,参与招投标项目815次;财产线索方面有商标信息72条,专利信息248条,著作权信息10条;此外企业还拥有行政许可177个。数据来源:企查查以上内容为证券之星据公开信息整理,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400006790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159180","BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680748827","title":"股市必读:三鑫医疗新发布《关于江西三鑫医疗科技股份有限公司2026年第二次临时股东会的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680748827","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680748827?lang=zh_cn&edition=full","pubTime":"2026-11-04 04:03","pubTimestamp":1793736198,"startTime":"0","endTime":"0","summary":"公司公告汇总关于江西三鑫医疗科技股份有限公司2026年第二次临时股东会的法律意见书江西三鑫医疗科技股份有限公司于2026年11月3日召开2026年第二次临时股东会,会议由董事会召集,董事长彭义兴主持,采用现场与网络投票相结合方式举行。2026年第二次临时股东会决议公告江西三鑫医疗科技股份有限公司于2026年11月3日召开2026年第二次临时股东会,审议通过《关于回购公司股份方案的议案》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400006186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678595464","title":"三鑫医疗:成立了专门的数字化业务职能部门","url":"https://stock-news.laohu8.com/highlight/detail?id=2678595464","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678595464?lang=zh_cn&edition=full","pubTime":"2026-10-28 16:09","pubTimestamp":1793174947,"startTime":"0","endTime":"0","summary":"证券之星消息,三鑫医疗10月28日在投资者关系平台上答复投资者关心的问题。这些信息在财报中未单独披露,能否告知大致范围三鑫医疗回复:尊敬的投资者,您好!近年来,公司高度重视数字化转型相关工作,成立了专门的数字化业务职能部门,配备了相应的专业人才和团队,按照年度预算规划稳步推进数字化转型与智能制造升级。如有其他应披露信息,公司将严格按照相关法律法规履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800033948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678445673","title":"三鑫医疗:2026年前三季度公允价值变动收益为278.36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678445673","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678445673?lang=zh_cn&edition=full","pubTime":"2026-10-28 16:06","pubTimestamp":1793174773,"startTime":"0","endTime":"0","summary":"另外,公司三季度整体毛利率降低的原因是什么?公司2026年前三季度公允价值变动收益为278.36万元,同比增长61.21%,主要系报告期末尚未赎回的闲置资金理财产品账面收益增加;报告期内不存在公允价值变动收益大幅降低的情形,详见公司已公开披露的《2026年第三季度报告》。2026年前三个季度,毛利率虽略有波动但整体相对稳定,短期波动主要受部分产品原材料市场价格变动影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800033594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678395701","title":"股市必读:三鑫医疗新发布《关于取得金融机构股票回购专项贷款承诺函的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678395701","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678395701?lang=zh_cn&edition=full","pubTime":"2026-10-26 04:21","pubTimestamp":1792959668,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘,三鑫医疗报收于9.28元,上涨2.09%,换手率2.4%,成交量8.75万手,成交额7900.68万元。当日关注点交易信息汇总:10月23日主力资金净流出559.81万元,占总成交额7.09%。公司近日收到中信银行南昌分行出具的《贷款承诺函》,贷款金额不超过5,200万元,期限不超过3年,用途为股票回购专项贷款。最终贷款以正式合同为准,具体回购情况以实际执行为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600001107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677961068","title":"三鑫医疗(300453)披露取得股票回购专项贷款承诺函公告,10月22日股价下跌1.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677961068","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677961068?lang=zh_cn&edition=full","pubTime":"2026-10-22 22:35","pubTimestamp":1792679713,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘,三鑫医疗报收于9.09元,较前一交易日下跌1.84%,最新总市值为47.46亿元。该股当日开盘9.22元,最高9.32元,最低9.08元,成交额达5084.52万元,换手率为1.52%。近日,江西三鑫医疗科技股份有限公司披露《关于取得金融机构股票回购专项贷款承诺函的公告》。公司近日收到中信银行南昌分行出具的《贷款承诺函》,贷款金额不超过5,200万元,期限不超过3年,用途为股票回购专项贷款。最终贷款以正式合同为准,具体回购情况以实际执行为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200042912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677011716","title":"股市必读:三鑫医疗新发布《关于控股二级子公司获得漏血监测器医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677011716","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677011716?lang=zh_cn&edition=full","pubTime":"2026-10-22 03:32","pubTimestamp":1792611130,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘,三鑫医疗报收于9.26元,上涨0.0%,换手率1.33%,成交量4.86万手,成交额4531.66万元。当日关注点交易信息汇总:10月21日主力资金净流出88.71万元,占总成交额1.96%;游资资金净流出506.42万元,占总成交额11.17%。公司公告汇总:控股二级子公司江西钶维肽生物科技有限公司获颁漏血监测器《医疗器械注册证》,属江西省第二类创新医疗器械,有效期至2031年10月15日。该产品采用生物电流识别技术,已被认定为江西省第二类创新医疗器械。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200003324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","BK0251","159883","BK1583","BK1574","300453","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675535185","title":"三鑫医疗(300453)披露股份回购方案公告,10月15日股价下跌1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675535185","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675535185?lang=zh_cn&edition=full","pubTime":"2026-10-15 22:56","pubTimestamp":1792076172,"startTime":"0","endTime":"0","summary":"截至2026年10月15日收盘,三鑫医疗报收于8.96元,较前一交易日下跌1.54%,最新总市值为46.78亿元。该股当日开盘9.03元,最高9.07元,最低8.91元,成交额达4094.67万元,换手率为1.25%。近日,江西三鑫医疗科技股份有限公司披露《关于股份回购方案的公告》。回购实施期限为自股东会审议通过之日起12个月内。本次回购不会导致公司控制权变更,亦不会影响公司上市地位。相关事项尚需提交股东会审议,存在未能获审议通过或回购无法实施等风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500040072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675258033","title":"三鑫医疗(300453.SZ)拟3000万元至6000万元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2675258033","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675258033?lang=zh_cn&edition=full","pubTime":"2026-10-15 21:19","pubTimestamp":1792070381,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三鑫医疗(300453.SZ)发布公告,公司拟3000万元至6000万元回购股份,回购股份价格不超过13.86元/股,将用于注销并相应减少公司注册资本。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1507969.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675580834","title":"三鑫医疗(300453.SZ)发布前三季度业绩,归母净利润2.1亿元,同比增长13.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675580834","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675580834?lang=zh_cn&edition=full","pubTime":"2026-10-15 21:16","pubTimestamp":1792070191,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三鑫医疗(300453.SZ)披露2026年第三季度报告,前三季度公司实现营收13.05亿元,同比增长11.78%;归母净利润2.1亿元,同比增长13.68%;扣非净利润1.93亿元,同比增长15.59%;基本每股收益0.4037元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1507967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675586683","title":"三鑫医疗:第三季度净利润7816.83万元 同比增长11.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675586683","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675586683?lang=zh_cn&edition=full","pubTime":"2026-10-15 18:50","pubTimestamp":1792061407,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674002334","title":"股市必读:三鑫医疗新发布《关于全资子公司变更医疗器械生产许可证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674002334","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674002334?lang=zh_cn&edition=full","pubTime":"2026-10-09 02:32","pubTimestamp":1791484331,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘,三鑫医疗报收于9.05元,上涨0.0%,换手率1.17%,成交量4.28万手,成交额3883.49万元。公司公告汇总:全资子公司云南三鑫医疗科技有限公司完成《医疗器械生产许可证》变更,企业负责人由万小平变更为彭海波,许可期限为2026年9月30日至2031年9月29日。公司公告汇总:截至2026年9月30日,公司已回购股份2,489,700股,占总股本0.48%,支付资金22,527,777元,回购进展符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900002355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","300453","159883","BK1100","09996","BK1574","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670255694","title":"三鑫医疗(300453)披露相关债券2026年跟踪评级报告,9月28日股价上涨0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670255694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670255694?lang=zh_cn&edition=full","pubTime":"2026-09-28 22:31","pubTimestamp":1790605879,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘,三鑫医疗报收于9.04元,较前一交易日上涨0.22%,最新总市值为47.2亿元。该股当日开盘9.02元,最高9.07元,最低8.86元,成交额达4164.47万元,换手率为1.27%。近日,江西三鑫医疗科技股份有限公司披露相关债券2026年跟踪评级报告。2026年上半年营业收入8.37亿元,净利润1.45亿元,总资产24.65亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800035213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669234144","title":"“药二代”密集走向台前,大多拥有海外名校背景,将如何接好“转型”这一棒?","url":"https://stock-news.laohu8.com/highlight/detail?id=2669234144","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669234144?lang=zh_cn&edition=full","pubTime":"2026-09-22 20:16","pubTimestamp":1790079360,"startTime":"0","endTime":"0","summary":"红星资本局注意到,“药二代”们正密集走向台前。与“创一代”不同的是,他们大多拥有海外名校背景,进入核心管理层的方式也各不相同。今年以来,还有多位“药二代”走向台前。多家药企处于业务转型期二代接棒或面临考验值得一提的是,近期迎来“药二代”上台的上市公司,多数处于业务转型期。“药二代”走向前台,企业如何完成转型,仍有待时间验证。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-09-22/doc-inistexc1956967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","IE00B031HY20.USD","BK0028","LU1008478684.HKD","LU0140636845.USD","LU1807302812.USD","300298","LU1152091168.USD","LU0067412154.USD","LU1226287529.USD","LU2039709279.SGD","600380","IE00BZ08YS42.EUR","LU1951186391.HKD","BK0187","LU1226287792.SGD","LU0315179316.USD","LU0326950275.SGD","BK0251","IE00BZ08YR35.GBP","300453","LU1226288170.HKD","SG9999004220.SGD","BK0188","LU1993786604.SGD","LU0501845795.SGD","LU1226288253.USD","688166","IE00BZ08YT58.USD","LU1226287875.USD","LU1152091754.HKD","BK0239","LU1813983027.USD","01093","LU0072913022.USD","HK0000165453.HKD","BK0077","BK0114","IE0008369823.USD","BK0046","LU0880133367.SGD","LU1960683339.HKD","IE0008368742.USD","LU1328277881.USD","IE00B543WZ88.USD","KURE","LU0314109678.HKD","BK0102","BK1521","000513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663809","title":"股市必读:三鑫医疗新发布《关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663809","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667663809?lang=zh_cn&edition=full","pubTime":"2026-09-14 04:23","pubTimestamp":1789330990,"startTime":"0","endTime":"0","summary":"公司公告汇总:董事会审议通过回购议案后,披露截至9月9日的前十名股东及前十名无限售条件股东持股情况,彭义兴分别持股24.70%和8.84%。回购报告书江西三鑫医疗科技股份有限公司拟使用自有资金回购公司A股股份,用于转换公司发行的可转换为股票的公司债券。预计回购股份数量为137.36万股至274.73万股,占公司总股本的0.26%至0.53%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794652317792,"stockEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0374},{"period":"3month","weight":-0.0531},{"period":"6month","weight":-0.022},{"period":"1year","weight":-0.0818},{"period":"ytd","weight":0.1182}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":-0.0353},{"period":"3month","weight":-0.0746},{"period":"6month","weight":-0.1212},{"period":"1year","weight":-0.0981},{"period":"ytd","weight":-0.0843}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江西三鑫医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"19629人(较上一季度增加5.53%)","perCapita":"18622股","listingDate":"2015-05-15","address":"江西省南昌市南昌县小蓝经济开发区富山大道999号","registeredCapital":"52191万元","survey":" 江西三鑫医疗科技股份有限公司的主营业务是医疗器械研发、制造、销售和服务。公司的主要产品是血液透析制水系统、一次性使用血液透析器、血液透析浓缩液、血液透析粉、一次性使用血液透析管路、一次性使用透析用留置针、透析液过滤器、一次性使用机用采血器、血液透析设备、血液透析滤过器、血液净化补液管路、连续性血液净化管路及附件。2025年,公司成功获批组建省级工业设计中心,荣获江西省先进级智能工厂、江西省数智工厂等荣誉,并入选省级培育工业互联网平台。数字化水平全面提升,智能化运营体系成效显著。","listedPrice":12.87},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三鑫医疗(300453)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三鑫医疗(300453)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三鑫医疗,300453,三鑫医疗股票,三鑫医疗股票老虎,三鑫医疗股票老虎国际,三鑫医疗行情,三鑫医疗股票行情,三鑫医疗股价,三鑫医疗股市,三鑫医疗股票价格,三鑫医疗股票交易,三鑫医疗股票购买,三鑫医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三鑫医疗(300453)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三鑫医疗(300453)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}